Your browser doesn't support javascript.
Challenges of Iranian Clinicians in Dealing with COVID-19: Taking Advantages of The Experiences in Wenzhou.
Li, Yuping; Tahamtani, Yaser; Totonchi, Mehdi; Chen, C Hengshui; Hashemian, Seyed Mohammad Reza; Amoozegar, Fatemeh; Zhang, Jin San; Gholampour, Yousef; Li, Xiaokun.
  • Li Y; Department of Pulmonary and Critical Care Medicine, The Firs t Affiliated Hospital of Wenzhou Medical University, China.
  • Tahamtani Y; Department of Diabetes, Obesity and Metabolism, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Totonchi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Chen CH; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Hashemian SMR; Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
  • Amoozegar F; Department of Pulmonary and Critical Care Medicine, The Firs t Affiliated Hospital of Wenzhou Medical University, China.
  • Zhang JS; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Gholampour Y; Noncommunicable diseases research center, Fasa University of Medical Sciences, Fasa, Iran.
  • Li X; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China. Electronic Address: Zhang_JinSan@wmu.edu.cn.
Cell J ; 22(Suppl 1): 155-165, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-708715
ABSTRACT
The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)- scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research Language: English Journal: Cell J Year: 2020 Document Type: Article Affiliation country: Cellj.2020.7604

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research Language: English Journal: Cell J Year: 2020 Document Type: Article Affiliation country: Cellj.2020.7604